Text Size

A A A

Search


 

Home | Clinical Trials

FDA Approved Drugs » 1997
Medical Areas: Neurology | Family Medicine | Genetic Disease

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

Carbatrol

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Elan Pharmaceuticals
Approval Status: Approved September 1997
Treatment Area: anticonvulsant and trigeminal neuralgia

General Information

Carbatrol by Elan Corp. has been approved as a treatment for epileptic seizures and trigeminal neuralgia. Carbatrol is recommended for use twice daily as an extended release drug.


 Back to Top | Printer Friendly Version

Get Involved

Stroke and You

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org